[Osteoporosis and immunity changes of cell-mediated immunity and T-cell subsets responding to 1 alpha (OH) vitamin D3]. 1983

T Sakamoto, and T Watanabe, and Y Sakamoto, and H Miyamoto, and S Yamaoka, and H Miura, and K Matsukawa, and T Matsui, and Y Nakao, and T Fujita

UI MeSH Term Description Entries
D006968 Hypersensitivity, Delayed An increased reactivity to specific antigens mediated not by antibodies but by sensitized T CELLS. Hypersensitivity, Tuberculin-Type,Hypersensitivity, Type IV,Tuberculin-Type Hypersensitivity,Type IV Hypersensitivity,Delayed Hypersensitivity,Delayed Hypersensitivities,Hypersensitivity, Tuberculin Type,Tuberculin Type Hypersensitivity,Tuberculin-Type Hypersensitivities,Type IV Hypersensitivities
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008903 Minerals Native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions. They may occur as individual crystals or may be disseminated in some other mineral or rock. (Grant & Hackh's Chemical Dictionary, 5th ed; McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Mineral
D010024 Osteoporosis Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis. Age-Related Osteoporosis,Bone Loss, Age-Related,Osteoporosis, Age-Related,Osteoporosis, Post-Traumatic,Osteoporosis, Senile,Senile Osteoporosis,Osteoporosis, Involutional,Age Related Osteoporosis,Age-Related Bone Loss,Age-Related Bone Losses,Age-Related Osteoporoses,Bone Loss, Age Related,Bone Losses, Age-Related,Osteoporoses,Osteoporoses, Age-Related,Osteoporoses, Senile,Osteoporosis, Age Related,Osteoporosis, Post Traumatic,Post-Traumatic Osteoporoses,Post-Traumatic Osteoporosis,Senile Osteoporoses
D001842 Bone and Bones A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principal cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX. Bone Tissue,Bone and Bone,Bone,Bones,Bones and Bone,Bones and Bone Tissue,Bony Apophyses,Bony Apophysis,Condyle,Apophyses, Bony,Apophysis, Bony,Bone Tissues,Condyles,Tissue, Bone,Tissues, Bone
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006887 Hydroxycholecalciferols Hydroxy analogs of vitamin D 3; (CHOLECALCIFEROL); including CALCIFEDIOL; CALCITRIOL; and 24,25-DIHYDROXYVITAMIN D 3. Hydroxyvitamins D,Hydroxycholecalciferol

Related Publications

T Sakamoto, and T Watanabe, and Y Sakamoto, and H Miyamoto, and S Yamaoka, and H Miura, and K Matsukawa, and T Matsui, and Y Nakao, and T Fujita
January 1984, Mineral and electrolyte metabolism,
T Sakamoto, and T Watanabe, and Y Sakamoto, and H Miyamoto, and S Yamaoka, and H Miura, and K Matsukawa, and T Matsui, and Y Nakao, and T Fujita
January 1995, Srpski arhiv za celokupno lekarstvo,
T Sakamoto, and T Watanabe, and Y Sakamoto, and H Miyamoto, and S Yamaoka, and H Miura, and K Matsukawa, and T Matsui, and Y Nakao, and T Fujita
March 1983, Rinsho shinkeigaku = Clinical neurology,
T Sakamoto, and T Watanabe, and Y Sakamoto, and H Miyamoto, and S Yamaoka, and H Miura, and K Matsukawa, and T Matsui, and Y Nakao, and T Fujita
January 1985, Acta vitaminologica et enzymologica,
T Sakamoto, and T Watanabe, and Y Sakamoto, and H Miyamoto, and S Yamaoka, and H Miura, and K Matsukawa, and T Matsui, and Y Nakao, and T Fujita
October 1987, Bone and mineral,
T Sakamoto, and T Watanabe, and Y Sakamoto, and H Miyamoto, and S Yamaoka, and H Miura, and K Matsukawa, and T Matsui, and Y Nakao, and T Fujita
January 1992, Acta anatomica,
T Sakamoto, and T Watanabe, and Y Sakamoto, and H Miyamoto, and S Yamaoka, and H Miura, and K Matsukawa, and T Matsui, and Y Nakao, and T Fujita
August 1980, Horumon to rinsho. Clinical endocrinology,
T Sakamoto, and T Watanabe, and Y Sakamoto, and H Miyamoto, and S Yamaoka, and H Miura, and K Matsukawa, and T Matsui, and Y Nakao, and T Fujita
April 1985, Endocrinologia japonica,
T Sakamoto, and T Watanabe, and Y Sakamoto, and H Miyamoto, and S Yamaoka, and H Miura, and K Matsukawa, and T Matsui, and Y Nakao, and T Fujita
June 1987, [Rinsho ketsueki] The Japanese journal of clinical hematology,
T Sakamoto, and T Watanabe, and Y Sakamoto, and H Miyamoto, and S Yamaoka, and H Miura, and K Matsukawa, and T Matsui, and Y Nakao, and T Fujita
April 1988, Gan to kagaku ryoho. Cancer & chemotherapy,
Copied contents to your clipboard!